WBG
ABBV icon

Wharton Business Group’s AbbVie ABBV Stock Holding History

Wharton Business Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$213K Buy
+846
New +$182K 0.01% 137
2018
Q1 		– Sell
-42,475
Closed -$4.11M – 101
2017
Q4 		$4.11M Hold
42,475
– – 0.43% 39
2017
Q3 		$3.77M Sell
42,475
-390
-0.9% -$29.7K 0.4% 40
2017
Q2 		$3.11M Sell
42,865
-1,195
-3% -$80.3K 0.33% 46
2017
Q1 		$2.87M Sell
44,060
-31,155
-41% -$1.96M 0.31% 48
2016
Q4 		$4.71M Buy
75,215
+24,255
+48% +$1.48M 0.56% 38
2016
Q3 		$3.21M Sell
50,960
-8,595
-14% -$556K 0.4% 48
2016
Q2 		$3.69M Buy
59,555
+4,021
+7% +$245K 0.44% 46
2016
Q1 		$3.17M Buy
55,534
+770
+1% +$42.9K 0.35% 52
2015
Q4 		$3.24M Sell
54,764
-325
-0.6% -$18.7K 0.32% 58
2015
Q3 		$3M Sell
55,089
-19,240
-26% -$1.25M 0.3% 59
2015
Q2 		$4.99M Sell
74,329
-5,225
-7% -$341K 0.33% 50
2015
Q1 		$4.66M Sell
79,554
-2,069
-3% -$125K 0.38% 53
2014
Q4 		$5.34M Sell
81,623
-33,076
-29% -$2.09M 0.44% 52
2014
Q3 		$6.63M Buy
114,699
+39,125
+52% +$2.17M 0.59% 47
2014
Q2 		$4.26M Sell
75,574
-54,263
-42% -$2.85M 0.47% 57
2014
Q1 		$6.67M Buy
129,837
+22,399
+21% +$1.13M 0.54% 52
2013
Q4 		$5.67M Buy
107,438
+44,163
+70% +$2.17M 0.48% 48
2013
Q3 		$2.83M Buy
63,275
+20,105
+47% +$891K 0.24% 72
2013
Q2 		$1.78M Buy
+43,170
New +$1.89M 0.16% 88

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wharton Business Group's ABBV Position: Q2 2026 in Review

Wharton Business Group opened a new position in AbbVie (ABBV) in Q2 2026: 846 shares worth $213K. The stake represents 0.01% of the portfolio and ranks #137 among its holdings. This is a return to the name: Wharton Business Group previously reported a position in ABBV as recently as Q4 2017.

Wharton Business Group first reported a position in ABBV in Q2 2013 and has held it in 20 quarters since. The position peaked at $6.67M in Q1 2014. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Wharton Business Group held 846 shares of AbbVie worth $213K as of Q2 2026.
  • AbbVie was a new Wharton Business Group position in Q2 2026.
  • AbbVie made up 0.01% of Wharton Business Group's portfolio in Q2 2026, its #137 holding.
  • Wharton Business Group first reported a position in AbbVie in Q2 2013 and has held it in 20 quarters since.
  • Wharton Business Group's AbbVie position peaked at $6.67M in Q1 2014.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wharton Business Group's 13F filing for Q2 2026, filed 10 Aug 2026.